WallStSmart

Equinix Inc (EQIX)vsNational Health Investors Inc (NHI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Equinix Inc generates 2341% more annual revenue ($9.26B vs $379.29M). NHI leads profitability with a 37.5% profit margin vs 14.6%. NHI appears more attractively valued with a PEG of 4.76. EQIX earns a higher WallStSmart Score of 50/100 (C-).

EQIX

Buy

50

out of 100

Grade: C-

Growth: 6.7Profit: 6.5Value: 2.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.55

NHI

Hold

48

out of 100

Grade: D+

Growth: 4.0Profit: 8.0Value: 6.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.46
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EQIXSignificantly Overvalued (-38.5%)

Margin of Safety

-38.5%

Fair Value

$626.41

Current Price

$1082.83

$456.42 premium

UndervaluedFair: $626.41Overvalued
NHIUndervalued (+32.5%)

Margin of Safety

+32.5%

Fair Value

$130.65

Current Price

$76.91

$53.74 discount

UndervaluedFair: $130.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EQIX3 strengths · Avg: 8.3/10
Market CapQuality
$106.79B9/10

Large-cap with strong market position

Operating MarginProfitability
21.5%8/10

Strong operational efficiency at 21.5%

EPS GrowthGrowth
22.9%8/10

Earnings expanding 22.9% YoY

NHI3 strengths · Avg: 9.3/10
Profit MarginProfitability
37.5%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
61.3%10/10

Strong operational efficiency at 61.3%

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Areas to Watch

EQIX4 concerns · Avg: 2.5/10
Debt/EquityHealth
1.613/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.912/10

Expensive relative to growth rate

P/E RatioValuation
74.6x2/10

Premium valuation, high expectations priced in

NHI4 concerns · Avg: 2.8/10
P/E RatioValuation
25.3x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.762/10

Expensive relative to growth rate

Revenue GrowthGrowth
-2.6%2/10

Revenue declined 2.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : EQIX

The strongest argument for EQIX centers on Market Cap, Operating Margin, EPS Growth.

Bull Case : NHI

The strongest argument for NHI centers on Profit Margin, Operating Margin, Price/Book. Profitability is solid with margins at 37.5% and operating margin at 61.3%.

Bear Case : EQIX

The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 74.6x leaves little room for execution misses. Debt-to-equity of 1.61 is elevated, increasing financial risk.

Bear Case : NHI

The primary concerns for NHI are P/E Ratio, Piotroski F-Score, PEG Ratio.

Key Dynamics to Monitor

EQIX profiles as a value stock while NHI is a declining play — different risk/reward profiles.

EQIX carries more volatility with a beta of 1.00 — expect wider price swings.

EQIX is growing revenue faster at 8.1% — sustainability is the question.

NHI generates stronger free cash flow (59M), providing more financial flexibility.

Bottom Line

EQIX scores higher overall (50/100 vs 48/100). NHI offers better value entry with a 32.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Equinix Inc

REAL ESTATE · REIT - SPECIALTY · USA

Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.

Visit Website →

National Health Investors Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in the sale and leaseback, joint ventures, mortgages, and interim financing of discretionary and medical-based home and investment investments. in needs.

Visit Website →

Want to dig deeper into these stocks?